DR3/LARD antibody (AA 1-210)
Quick Overview for DR3/LARD antibody (AA 1-210) (ABIN604923)
Target
See all DR3/LARD (TNFRSF25) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1-210
-
Specificity
- Human DR3.
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Recombinant protein fragment containing a sequence corresponding to a region within amino acids 1 and 210 of Human DR3.
Type of Immunogen: Recombinant protein
-
-
-
-
Application Notes
- Approved: IHC, IHC-P (10 μg/mL), WB (1:500 - 1:3000)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 0.1 M Tris-glycine, pH 7, 10 % Glycerol, 0.01 % Thimerosal
-
Preservative
- Thimerosal (Merthiolate)
-
Precaution of Use
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Minimize freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot and store at -20°C. Avoid freeze-thaw cycles.
-
-
- DR3/LARD (TNFRSF25) (Tumor Necrosis Factor Receptor Superfamily, Member 25 (TNFRSF25))
-
Alternative Name
- TNFRSF25 / DR3
-
Background
-
Name/Gene ID: TNFRSF25
Family: TNF Receptor
Synonyms: TNFRSF25, APO-3, APO3, DDR3, Death receptor 3, DR3, Death receptor beta, LARD, Protein WSL, TR3, WSL, WSL-1, WSL-LR, Apoptosis inducing receptor, TNFRSF12, WSL1, Protein WSL-1, TRAMP -
Gene ID
- 8718
-
UniProt
- Q93038
-
Pathways
- Apoptosis
Target
-